IBDEI1M5 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,522,0)
 ;;=PERSONAL HX OF MENTAL DISORDER^35^42
 ;;^UTILITY(U,$J,358.4,523,0)
 ;;=PERSONS SEEKING CONSULT^37^42
 ;;^UTILITY(U,$J,358.4,524,0)
 ;;=POSTPROCEDURAL STATES^38^42
 ;;^UTILITY(U,$J,358.4,525,0)
 ;;=PSYCHOSOCIAL CIRCUMSTANCES^39^42
 ;;^UTILITY(U,$J,358.4,526,0)
 ;;=SENSES/FUNCTION PROBLEMS^44^42
 ;;^UTILITY(U,$J,358.4,527,0)
 ;;=UNAVAILABILITY OF MED FACILITY CARE^60^42
 ;;^UTILITY(U,$J,358.4,528,0)
 ;;=UPPER LIMB AMPUTATION STATUS^61^42
 ;;^UTILITY(U,$J,358.4,529,0)
 ;;=MD/PA/NP E&M CONSULTATIONS^3^43
 ;;^UTILITY(U,$J,358.4,530,0)
 ;;=MD/PA/NP-ESTABLISHED PATIENT^2^43
 ;;^UTILITY(U,$J,358.4,531,0)
 ;;=MD/PA/NP-NEW PATIENT^1^43
 ;;^UTILITY(U,$J,358.4,532,0)
 ;;=MD/PA/NP HOME VISIT-NEW PATIENT^4^43
 ;;^UTILITY(U,$J,358.4,533,0)
 ;;=MD/PA/NP HOME VISIT-ESTABLISHED PATIENT^5^43
 ;;^UTILITY(U,$J,358.4,534,0)
 ;;=OUTPT NEW PATIENT^3^44
 ;;^UTILITY(U,$J,358.4,535,0)
 ;;=OUTPT ESTABLISHED PATIENT^2^44
 ;;^UTILITY(U,$J,358.4,536,0)
 ;;=OUTPT CONSULTATIONS^4^44
 ;;^UTILITY(U,$J,358.4,537,0)
 ;;=NURSING VISIT ONLY^1^44
 ;;^UTILITY(U,$J,358.4,538,0)
 ;;=INITIAL OBSERVATION^9^44
 ;;^UTILITY(U,$J,358.4,539,0)
 ;;=SAME DAY ADM/DISCHARGE^12^44
 ;;^UTILITY(U,$J,358.4,540,0)
 ;;=INPT CONSULTATIONS^5^44
 ;;^UTILITY(U,$J,358.4,541,0)
 ;;=INITIAL HOSPITAL CARE^6^44
 ;;^UTILITY(U,$J,358.4,542,0)
 ;;=SUBSEQUENT HOSPITAL CARE^7^44
 ;;^UTILITY(U,$J,358.4,543,0)
 ;;=HOSPITAL CARE D/C SERVICES^8^44
 ;;^UTILITY(U,$J,358.4,544,0)
 ;;=SUBSEQUENT OBSERVATION CARE^10^44
 ;;^UTILITY(U,$J,358.4,545,0)
 ;;=OBSERVATION CARE D/C SERVICES^11^44
 ;;^UTILITY(U,$J,358.4,546,0)
 ;;=PROLONGED SERVICES^5^45
 ;;^UTILITY(U,$J,358.4,547,0)
 ;;=VENOUS^7^45
 ;;^UTILITY(U,$J,358.4,548,0)
 ;;=BP MONITORING^1^45
 ;;^UTILITY(U,$J,358.4,549,0)
 ;;=MEDICATION^4^45
 ;;^UTILITY(U,$J,358.4,550,0)
 ;;=CARDIOVASCULAR^2^45
 ;;^UTILITY(U,$J,358.4,551,0)
 ;;=CATHETER^3^45
 ;;^UTILITY(U,$J,358.4,552,0)
 ;;=TEAM CONFERENCE^6^45
 ;;^UTILITY(U,$J,358.4,553,0)
 ;;=HEMODIALYSIS-ESRD^14^46
 ;;^UTILITY(U,$J,358.4,554,0)
 ;;=PERITONEAL DIALYSIS ENCOUNTER^23^46
 ;;^UTILITY(U,$J,358.4,555,0)
 ;;=CARDIOLOGY/CARDIORENAL SYNDROME^2^46
 ;;^UTILITY(U,$J,358.4,556,0)
 ;;=COMPLICATIONS/OTHER^4^46
 ;;^UTILITY(U,$J,358.4,557,0)
 ;;=CYSTIC KIDNEY DISEASE^5^46
 ;;^UTILITY(U,$J,358.4,558,0)
 ;;=DIABETES/DIABETIC RENAL DISEASE^6^46
 ;;^UTILITY(U,$J,358.4,559,0)
 ;;=FLUID/ELECTROLYTE DISORDER^8^46
 ;;^UTILITY(U,$J,358.4,560,0)
 ;;=GENERAL SYMPTOMS^9^46
 ;;^UTILITY(U,$J,358.4,561,0)
 ;;=GENITAL/URINARY^10^46
 ;;^UTILITY(U,$J,358.4,562,0)
 ;;=HEMATOLOGY^12^46
 ;;^UTILITY(U,$J,358.4,563,0)
 ;;=HYPERTENSION^15^46
 ;;^UTILITY(U,$J,358.4,564,0)
 ;;=INFECTIOUS DISEASE^16^46
 ;;^UTILITY(U,$J,358.4,565,0)
 ;;=NEPHRITIS GLUMERULONEPHRITIS^18^46
 ;;^UTILITY(U,$J,358.4,566,0)
 ;;=NEPHRITIS INTERSTITIAL^19^46
 ;;^UTILITY(U,$J,358.4,567,0)
 ;;=NEPHROTIC SYNDROME^21^46
 ;;^UTILITY(U,$J,358.4,568,0)
 ;;=OBSTRUCTIVE UROPATHY^22^46
 ;;^UTILITY(U,$J,358.4,569,0)
 ;;=TRANSPLANT^26^46
 ;;^UTILITY(U,$J,358.4,570,0)
 ;;=CKD/KIDNEY DISEASE^3^46
 ;;^UTILITY(U,$J,358.4,571,0)
 ;;=HEMODIALYSIS-AKI^13^46
 ;;^UTILITY(U,$J,358.4,572,0)
 ;;=ACUTE KIDNEY INJURY^1^46
 ;;^UTILITY(U,$J,358.4,573,0)
 ;;=GLOMERULAR DISEASE^11^46
 ;;^UTILITY(U,$J,358.4,574,0)
 ;;=KIDNEY INVOLVMNT IN SYSTEMIC DISEASE^17^46
 ;;^UTILITY(U,$J,358.4,575,0)
 ;;=NEPHROLITHASIS^20^46
 ;;^UTILITY(U,$J,358.4,576,0)
 ;;=POISONING & INTOXICATIONS^24^46
